Autoantibody diagnostics in clinical practice

Autoimmunity Reviews

Volumn 11, Issue 3, 2012, Pages 207-211

  Conrad, Karsten ^a   Roggenbuck, Dirk ^b   Reinhold, Dirk ^c   Sack, Ulrich ^d  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b GA GENERIC ASSAYS GMBH   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Autoantibodies; Autoimmune diseases; Diagnostics

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; MEMBRANE PROTEIN;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; EPITOPE MAPPING; ETHNIC DIFFERENCE; GENETIC VARIABILITY; IMMUNE RESPONSE; MOLECULAR RECOGNITION; MYELOOPTIC NEUROPATHY; PREDICTIVE VALUE; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TOTAL QUALITY MANAGEMENT;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; COST-BENEFIT ANALYSIS; EARLY DIAGNOSIS; HUMANS; MANAGEMENT QUALITY CIRCLES; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; REFERENCE STANDARDS;

EID: 84855940327     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.05.014     Document Type: Review

References (29)

1. Takeda I., Rayno K., Wolfson-Reichlin M., Reichlin M. Heterogeneity of anti-dsDNA antibodies in their cross-reaction with ribosomal P proteins. J Autoimmun 1999, 13:423-428.
2. Zhao Z., Weinstein E., Tuzova M., Davidson A., Mundel P., Marambio P., et al. Cross-reactivity of human lupus anti-DNA antibodies with a-actinin and nephritogenic potential. Arthritis Rheum 2005, 52:522-530.
3. Greidinger E.L., Casciola-Rosen L., Morris S.M., Hoffman R.W., Rosen A. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations. Arthritis Rheum 2000, 43:881-888.
4. Reveille J.D. Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003, 5:160-167.
5. Cooper G.S., Parks C.G., Treadwell E.L., StClair E.W., Gilkeson G.S., Cohen P.L., et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 2002, 11:161-167.
6. Kuwana M., Kaburaki J., Arnett F.C., Howard R.F., Medsger T.A., Wright T.M. Influence of ethnic background on clinical and serologic features in patients with systemic sclerosis and anti-DNA topoisomerase I antibody. Arthritis Rheum 1999, 42:365-374.
7. Wang J., Satoh M., Kabir F., Shaw M., Domingo M.A., Mansoor R., et al. Increased prevalence of autoantibodies to Ku antigen in African American versus white patients with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2367-2370.
8. Airbuckle M.R., McClain M.T., Rubertone M.V., Scofield H., Dennis G.J., James J.A., et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003, 349:1526-1533.
9. Nielen M.M.J., van Schaardenburg D., Reesink H.W., van de Stadt R.J., van der Horst-Bruinsma I.E., de Koning M.H.M.T., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004, 50:380-386.
10. Conrad K., Mehlhorn J. Diagnostic and prognostic relevance of autoantibodies in uranium miners. Int Arch Allergy Immunol 2000, 123:77-91.
11. Nell V.P., Machold K.P., Eberl G., Stamm T.A., Uffmann M., Smolen J.S. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004, 43:906-914.
12. Steen V., Medsger T.A. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516-522.
13. Roggenbuck D., Hausdorf G., Feist E., Reinhold D., Jungblut P.R., Porstmann T., et al. Identification of GP2, the major zymogen granule membrane glycoprotein, as the autoantigen of pancreatic antibodies in Crohn's disease. Gut 2009, 58:1620-1628.
14. Lennon V.A., Kryzer T.J., Pittock S.J., Verkman A.S., Hinson S.R. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202:473-477.
15. Dalmau J., Tuzun E., Wu H.Y., Masjuan J., Rossi J.E., Voloschin A., et al. Paraneoplastic anti-N-methyl-Daspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
16. Sturgess A., John Edmonds J. Improving the effectiveness of autoantibody testing in the clinic. Autoimmun Rev 2002, 1:273-278.
17. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 2009, 8:543-548.
18. Conrad K., Roggenbuck D., Reinhold D., Dörner T. Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 2009, 9:431-435.
19. Villalta D., Tozzoli R., Tonutti E., Bizzaro N. The laboratory approach to the diagnosis of autoimmune diseases: is it time to change?. Autoimmun Rev 2007, 6:359-365.
20. Damoiseaux J.G.M.C., Cohen Tervaert J.W. From ANA to ENA: how to proceed?. Autoimmun Rev 2006, 5:10-17.
21. Hiemann R., Büttner T., Krieger T., Roggenbuck D., Sack U., Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009, 9:17-22.
22. Großmann K., Roggenbuck D., Schröder C., Conrad K., Schierack P., Sack U. Multiplex assessment of non-organ specific autoantibodies with a novel microbead-based immunoassay. Cytometry A 2011, 79A:118-125.
23. Tozzoli R. Recent advances in diagnostic technologies and their impact in autoimmune diseases. Autoimmun Rev 2007, 6:334-340.
24. Fritzler M.J., Wiik A., Fritzler M.L., Barr S.G. The use and abuse of commercial kits used to detect autoantibodies. Arthritis Res Ther 2003, 5:192-201.
25. Chan E.K.L., Fritzler M.J., Wiik A., Andrade L.E.C., Reeves W.H., Tincani, Meroni P.L., et al. AutoAbSC.Org-Autoantibody Standardization Committee in 2006. Autoimmun Rev 2007, 6:577-580.
26. Wiik A., Gordon T.P., Kavanaugh A.F., Lahita R.G., Reeves W., van Venrooij W.J., et al. Cutting edge diagnostics in rheumatology: the role of patients, clinicians, and laboratory scientists in optimizing the use of autoimmune serology. Arthritis Rheum (Arthritis Care Res) 2004, 51:291-298.
27. Wiik A., Cervera R., Haass M., Kallenberg C., Khamashta M., Meroni P.L., et al. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders. Lupus 2006, 15:391-396.
28. Sack U., Conrad K., Csernok E., Frank I., Hiepe F., Krieger T., et al. Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci 2009, 1173:166-173.
29. Tonutti E., Visentini D., Bizzaro N. Interpretative comments on autoantibody tests. Autoimmun Rev 2007, 6:341-346.